From: Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence
Name | Induction of adenomyosis | Ozagrel treatment | Platelet depletion | R 2 |
---|---|---|---|---|
Extent of CD41+ platelet aggregation | ↑ *** | ↓ *** | ↓ *** | 0.54 |
Number of infiltrated F4/80+ macrophages | ↑ *** | ↓ ** | ↓ * | 0.30 |
Phosph-p65 | ↑ *** | ↓ ** | ↓ ** | 0.31 |
PR-B | ↓ *** | ↑ *** | ↑ *** | 0.73 |
COX-2 | ↑ *** | ↓ *** | ↓ *** | 0.48 |
TRPV1 | ↑ *** | ↓ *** | ↓ *** | 0.47 |
OTR | ↑ *** | ↓ *** | ↓ *** | 0.58 |
Collagen I | ↑ *** | ↓ *** | ↓ * | 0.29 |
Collagen IV | ↑ *** | ↓ ** | ↓ *** | 0.33 |
Myometrial OTR | ↑ *** | ↓ *** | ↓ *** | 0.77 |